Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation

被引:14
|
作者
Rowinska, Zuzanna [1 ,2 ,3 ]
Koeppel, Thomas A. [4 ]
Sanati, Maryam [3 ]
Schelzig, Hubert [5 ]
Jankowski, Joachim [3 ,6 ]
Weber, Christian [7 ]
Zernecke, Alma [8 ]
Liehn, Elisa A. [3 ,9 ]
机构
[1] Ruhr Univ Bochum, St Josef Hosp, Dept Vasc Surg, Bochum, Germany
[2] Ruhr Univ Bochum, St Josef Hosp, Interdisciplinary Vein Ctr, Bochum, Germany
[3] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res, Aachen, Germany
[4] Hosp Asklepios St Georg Hamburg, Div Vasc Surg, Hamburg, Germany
[5] Dusseldorf Univ Hosp, Dept Vasc & Endovasc Surg, Dusseldorf, Germany
[6] Maastricht Univ, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands
[7] Ludwig Maximilian Univ Munich, Inst Prevent & Epidemiol Cardiovasc Dis, Munich, Germany
[8] Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany
[9] Univ Med & Pharm, Human Genet Lab, Craiova, Romania
来源
PLOS ONE | 2017年 / 12卷 / 02期
关键词
SMOOTH-MUSCLE-CELLS; ALLOGRAFT-REJECTION; LESION FORMATION; GROWTH-FACTOR; MOUSE MODELS; FRACTALKINE; CX(3)CR1; MICE; ARTERIOSCLEROSIS; ATHEROGENESIS;
D O I
10.1371/journal.pone.0170644
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background The CX3C chemokine receptor CX3CR1 is expressed on monocytes as well as tissue resident cells, such as smooth muscle cells ( SMCs). Its role in atherosclerotic tissue remodeling of the aorta after transplantation has not been investigated. Methods We here have orthotopically transplanted infrarenal Cx3cr1(-/-) Apoe(-/-) and Cx3cr1(+/+) Apoe(-/-)aortic segments into Apoe(-/-) mice, as well as Apoe(-/-) aortic segments into Cx3cr1(-/-) Apoe(-/-)mice. The intimal plaque size and cellular plaque composition of the transplanted aortic segment were analyzed after four weeks of atherogenic diet. Results Transplantation of Cx3cr(-/-) Apoe(-/-) aortic segments into Apoe(-/-) mice resulted in reduced atherosclerotic plaque formation compared to plaque size in Apoe(-/-) or Cx3cr1(-/-) Apoe(-/-) mice after transplantation of Apoe(-/-) aortas. This reduction in lesion formation was associated with reduced numbers of lesional SMCs but not macrophages within the transplanted Cx3cr(-/-) Apoe(-/-) aortic segment. No differences in frequencies of proliferating and apoptotic cells could be observed. Conclusion These results indicate that CX3CR1 on resident vessel wall cells plays a key role in atherosclerotic plaque formation in transplanted aortic grafts. Targeting of vascular CX3CL1/ CX3CR1 may therefore be explored as a therapeutic option in vascular transplantation procedures.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis
    Fang, IM
    Lin, CP
    Yang, CM
    Chen, MS
    Yang, CH
    MOLECULAR VISION, 2005, 11 (52): : 443 - 451
  • [2] Identification of CX3CR1 -: A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1
    Combadiere, C
    Salzwedel, K
    Smith, ED
    Tiffany, HL
    Berger, EA
    Murphy, PM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 23799 - 23804
  • [3] High expression of CX3C chemokine receptor 1 (CX3CR1) in human carotid plaques is associated with vulnerability of the lesions
    Masztalewicz, Marta
    Nowacki, Przemystaw
    Szydlowski, Lukasz
    Zukowski, Maciej
    Gutowski, Piotr
    FOLIA NEUROPATHOLOGICA, 2017, 55 (02) : 174 - 181
  • [4] Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its interactions with antagonist and agonist ligands
    Goode-Romero, Guillermo
    Dominguez, Laura
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 117
  • [5] An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis
    Pezeshkian, Fatemehsadat
    Shahriarirad, Reza
    Mahram, Hadiseh
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (10)
  • [6] Functional analysis of the chemokine receptor CX3CR1
    Chen, YM
    Green, S
    Quehenberger, O
    FASEB JOURNAL, 2005, 19 (05): : A1419 - A1419
  • [7] Pharmacological Inhibition of the Chemokine Receptor, CX3CR1, Reduces Atherosclerosis in Mice
    Poupel, Lucie
    Boissonnas, Alexandre
    Hermand, Patricia
    Dorgham, Karim
    Guyon, Elodie
    Auvynet, Constance
    Saint Charles, Flora
    Lesnik, Philippe
    Deterre, Philippe
    Combadiere, Christophe
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (10) : 2297 - 2305
  • [8] Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)
    Lucas, AD
    Bursill, C
    Guzik, TJ
    Sadowski, J
    Channon, KM
    Greaves, DR
    CIRCULATION, 2003, 108 (20) : 2498 - 2504
  • [9] E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Mice with Colitis
    Wakita, Hisashi
    Yanagawa, Tatsuya
    Kuboi, Yoshikazu
    Imai, Toshio
    MOLECULAR PHARMACOLOGY, 2017, 92 (05) : 502 - 509
  • [10] Fractalkine/CX3CR1 and atherosclerosis
    Liu, Hong
    Jiang, Deqian
    CLINICA CHIMICA ACTA, 2011, 412 (13-14) : 1180 - 1186